Biotech Investors & VC Firms in North America

1593 firms in this list, with a median first check of $500K. 347 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
AC Aceleradora Litoral BRDMDMDV6 people	88🔒	Santa Fe	AR	Seed	$500K	+ Add to CRM
AC ACORN BIOVENTURES GSAHML3 people	88🔒	New York	US	Seed–Late Stage	—	+ Add to CRM
RO Rocky Point Ventures PCRHWL3 people	88🔒	Austin	US	Seed–Series A	—	+ Add to CRM
TA Tachyon Ventures CENDET3 people	88🔒	Los Angeles	US	Seed–Series A	—	+ Add to CRM
VA Valhalla Ventures MKDMRP3 people · Follows rounds	88🔒	New York	US	Pre-Seed–Seed	$10M	+ Add to CRM
BE Bering Capital EZPSCAGP8 people	88🔒	San Francisco	US	Seed–Late Stage	—	+ Add to CRM
BO Boston Millennia Partners DCMHRRBL8 people	88🔒	Boston	US	Seed–Late Stage	$3M – $5M	+ Add to CRM
FL Fletcher Spaght, Inc. PSBGBSLG8 people	88🔒	Boston	US	Late Stage	—	+ Add to CRM
WA WARF CBGKGNJY8 people	88🔒	Madison	US	Seed–Series A	—	+ Add to CRM
CA Carbon Silicon NBTS2 people · Follows rounds	88🔒	Carson City	US	Pre-Seed–Series A	$100K – $500K	+ Add to CRM
GO Gossamer Capital CBJS2 people	88🔒	Denver	US	Pre-Seed–Seed	—	+ Add to CRM
AL Allerfund Ventures, Llc COLSAMLS4 people	88🔒	New York	US	Seed–Series A	—	+ Add to CRM
CR Crossroads Health Ventures TGVWCLCW6 people	88🔒	Indianapolis	US	Seed–Series A	—	+ Add to CRM
GO Gore Range Capital ERHCCN3 people	88🔒	Southlake	US	Series A–Late Stage	$500K – $5M	+ Add to CRM
NO Northtech Capital Investors SAGFJM3 people	88🔒	Cambridge	CA	Seed–Series A	$25K – $200K	+ Add to CRM
PB PBM Capital JRJPSGDZ6 people	88🔒	Charlottesville	US	Series A–Late Stage	—	+ Add to CRM
GL Global Startups Accelerator (formerly LatAm Startups) MLAACRMS8 people	88🔒	Toronto	CA	Pre-Seed–Seed	—	+ Add to CRM
HA HARPER COURT VENTURES DRKMARKM4 people	88🔒	Chicago	US	Pre-Seed–Series A	—	+ Add to CRM
EX Excell Partners AZRKTM3 people	88🔒	Rochester	US	Pre-Seed–Series A	$100K – $1.5M	+ Add to CRM
HI Highbury Holdings DLKPYW3 people · Follows rounds	88🔒	Seattle	US	Seed–Series B	$100K – $10M	+ Add to CRM
AP APOLLO PROJECTS SAMA2 people · Follows rounds	88🔒	San Francisco	US	Seed–Series B	—	+ Add to CRM
SO Soleus Capital GLSJ2 people	88🔒	Greenwich	US	Late Stage	—	+ Add to CRM
AB Aberdare Ventures SV1 person · Follows rounds	88🔒	San Francisco	US	Seed–Series A	$500K – $15M	+ Add to CRM
CE Cencora Ventures LD1 person	88🔒	San Francisco	US	Seed–Series B	$1M – $10M	+ Add to CRM

Aceleradora Litoral

Santa FeSeed$500K

BRDMDMDV6 people

ACORN BIOVENTURES

New YorkSeed–Late Stage

GSAHML3 people

Rocky Point Ventures

AustinSeed–Series A

PCRHWL3 people

Tachyon Ventures

Los AngelesSeed–Series A

CENDET3 people

Valhalla Ventures

New YorkPre-Seed–Seed$10M

MKDMRP3 people

Bering Capital

San FranciscoSeed–Late Stage

EZPSCAGP8 people

Boston Millennia Partners

BostonSeed–Late Stage$3M – $5M

DCMHRRBL8 people

Fletcher Spaght, Inc.

BostonLate Stage

PSBGBSLG8 people

WARF

MadisonSeed–Series A

CBGKGNJY8 people

Carbon Silicon

Carson CityPre-Seed–Series A$100K – $500K

NBTS2 people

Gossamer Capital

DenverPre-Seed–Seed

CBJS2 people

Allerfund Ventures, Llc

New YorkSeed–Series A

COLSAMLS4 people

Crossroads Health Ventures

IndianapolisSeed–Series A

TGVWCLCW6 people

Gore Range Capital

SouthlakeSeries A–Late Stage$500K – $5M

ERHCCN3 people

Northtech Capital Investors

CambridgeSeed–Series A$25K – $200K

SAGFJM3 people

PBM Capital

CharlottesvilleSeries A–Late Stage

JRJPSGDZ6 people

Global Startups Accelerator (formerly LatAm Startups)

TorontoPre-Seed–Seed

MLAACRMS8 people

HARPER COURT VENTURES

ChicagoPre-Seed–Series A

DRKMARKM4 people

Excell Partners

RochesterPre-Seed–Series A$100K – $1.5M

AZRKTM3 people

Highbury Holdings

SeattleSeed–Series B$100K – $10M

DLKPYW3 people

APOLLO PROJECTS

San FranciscoSeed–Series B

SAMA2 people

Soleus Capital

GreenwichLate Stage

GLSJ2 people

Aberdare Ventures

San FranciscoSeed–Series A$500K – $15M

SV1 person

Cencora Ventures

San FranciscoSeed–Series B$1M – $10M

LD1 person

Data sourced from public filings and firms' own websites — see our methodology.